Skip to main content
. Author manuscript; available in PMC: 2022 Jun 30.
Published in final edited form as: Pain. 2020 Oct;161(10):2330–2343. doi: 10.1097/j.pain.0000000000001926

Figure 2.

Figure 2.

Cancer cell line supernatant evokes orofacial nociceptive behavior in male mice. (A) Experimental timeline for the cell line supernatant model of oral cancer pain. Adult C57BL/6 male mice were trained in a dolognawmeter over 4 weeks or until a consistent baseline was achieved. Three additional baseline trials were completed and then mice underwent 3 consecutive injections of cell line supernatant followed by assessment in the dolognawmeter (Postinjection Gnaw-Time Measurement). There was no change in gnaw-time between groups; therefore, the mean of the 3 baseline trials for each group were calculated and analyzed as a percent change. (B) Pooled data for Pre-Treatment and Post-treatment trials as well as (C) individual values for each mouse in the Post-Treatment Trial are represented as a percent change from the average baseline gnaw-time (two-way ANOVA, ** P < 0.01). ANOVA, analysis of variance.